Chief of Surgical Services, Chairman, Department of Surgery and Chief, Ochsner Multi-Organ Transplant Center
General Surgery
Dr. George E. Loss Jr., MD
|
|
Give Review
George Loss practices General Surgery. He attended University of Arkansas for Medical Sciences College of Medicine. University of Arkansas for Medical Sciences College of Medicine is ranked 83/35 in Research/PrimaryCare. He received 3 awards: "Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Dr. George E. Loss Jr. is a published physician as well. He has 35 publications published. The latest was: Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.
Publications
- Adverse Cardiac Events After Orthotropic Liver Transplantation: A Cross-sectional Study in 389 Consecutive Patients.
- Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment.
- Excellent liver retransplantation outcomes in hepatitis C-infected recipients.
- Reflections on a post-katrina transplant program.
- Improving Donor Livers by Inhibiting TNF-α Production.
- Induction with rabbit antithymocyte globulin versus induction with corticosteroids in liver transplantation: impact on recurrent hepatitis C virus infection.
- Early postoperative hepatic sonography as a predictor of vascular and biliary complications in adult orthotopic liver transplant patients.
- Miller fisher variant of guillain-barre syndrome requiring a cardiac pacemaker in a patient on tacrolimus after liver transplantation.
- Tolerance: is it worth the risk?
- Does lamivudine prophylaxis eradicate persistent HBV DNA from allografts derived from anti-HBc-positive donors?
- Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy.
- Innovative medical management with resection for successful treatment of pulmonary mucormycosis despite diagnostic delay.
- Impaired Expression of Type I and Type II Interferon Receptors in HCV-Associated Chronic Liver Disease and Liver Cirrhosis.
- Reversal of delayed hyperacute renal allograft rejection with a tacrolimus-based therapeutic regimen.
- Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach.
- Cyclosporine versus cyclosporine microemulsion in pediatric liver transplant recipients.
- Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation.
- Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression.
- Successful use of tacrolimus for initial rejection episodes after liver transplantation.
- An analysis of hepatic retransplantation in children.
- Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.
- Combined liver and kidney transplantation in children.
- Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation.
- Steroid-free immunosuppression through thymoglobulin induction in liver transplantation.
- Transplantation of livers from hbc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary results.
- Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial.
- Treatment of recurrent hepatitis C in liver transplant recipients: is there any histologic benefit?
- Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients.
- Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?
- Donor transmission of malignant melanoma to a liver graft recipient: case report and literature review.
- Immunogenetic susceptibility to diabetes mellitus in patients with liver disease.
- Duplication of MER115 on chromosome 4 in patients with primary biliary cirrhosis.
- TIMP-3 ameliorates hepatic ischemia/reperfusion injury through inhibition of tumor necrosis factor-alpha-converting enzyme activity in rats.
- Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis.
Schools
University Of Arkansas College Of Medicine
University Of Chicago Hospitals
MultiOrgan Transplant Fellowhip At The University Of Chicago Hospitals
Dartmouth College
Procedures Preformed
- Hepatectomy
- Liver Transplant
- Renal Transplant and Nephrectomy
Doctors Specialties
- General Surgery
- Pediatric Transplant Surgery
- Renal Transplant Surgery
- Transplant Surgery
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
University of Chicago -
University of Arkansas for Medical Sciences College of Medicine
Hospital
-
Ochsner Medical Center
Helpful Reviews
Similar Doctors
|
Dr. Claudie S. Sheahan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward S. Lindsey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jacob M. Hebert, MD |
|
Dr. Ari J. Cohen, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Humberto E. Bohorquez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fabienne L. Gray, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter W. Lundberg, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ian C. Carmody, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy E. Rivere, MD |
|
|
Dr. Alison C. Heidt, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Reinaldo E. Rampolla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James Korndorffer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melvil B. Myers Jr., MD |
|
|
Dr. Dietric L. Hennings, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joshua A. Sibille, MD |
|
|
Dr. John-Mark O. Odero, MD |
|
|
Dr. William S. Steinhardt Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lee M. Morris, MD |